Date: November 7-10, 2001
Location: Marriott Marquis, New York, New York, USA
Symposium Web Page: www.mssmtv.org
Sponsors: Page & William Black Post-Graduate School and Chemotherapy Foundation
Who Should Attend: Oncologists, immunologists, radiologists, hematologists, physicians with secondary in oncology, nurses, pharmacists, other health care professionals
Objectives: Professional education for oncologists for control and cure of cancer
Topics: Strategies for control and cure of breast, ovarian, prostate, GI, bladder, hematologic malignancies, melanomas, lung and brain tumors, informatics, cancer research, chemo-prevention, monoclonal antibodies, molecular targeted agents.
Agenda: Practical applications for the medical oncologist of multimodality therapies in diverse neoplastic diseases. International faculty of clinical investigators present results of clinical trials, new combination chemotherapy regimens, tumor vaccines, gene chips, immunotherapy, angiogenesis inhibition, biomodulation and other developing biotherapies.
Registration Info: Contact: Jaclyn Silverman, Conference Coordinator, Mount Sinai School of Medicine, Division of Medical Oncology, Box 1178, New York, NY 10029
Fees: Physicians: $425 Pharmacists: $250 Nurses/Fellows/Other Health Care Professionals: $150
Continuing Education: Available for physicians, nurses, and pharmacists.English
Jan 20, 2011 - The combination of chemotherapy with intensity-modulated radiation therapy is equally as effective for the treatment of anal cancer after two years as the combination of chemotherapy and conventionally delivered radiation therapy, as well as less toxic, according to a study presented at the American Society of Clinical Oncology's annual Gastrointestinal Cancers Symposium, held from Jan. 20 to 22 in San Francisco.